rruys PW, Chevalier B, Dudek D, et al.A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by denovo native coronary artery lesions (ABSORBⅡ) :An interim 1-year analysis of clinical and procedural secondary es from a randomised controlled trial[J].Lancet, 2015, 385 (9962) :43-54. Р[32]Gao R, Yang Y, Han Y, et al.Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease:ABSORBChina trial[J].J Am Coll Cardiol, 2015, 66 (21) :2298-2309. Р[33]Kimura T, Kozuma K, Tanabe K, et al.A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs.everolimus-eluting metallic stents in patients with coronary artery disease:ABSORB Japan[J].Eur Heart J, 2015, 36 (47) :3332-3342.
全文预览
